Sponsored by Cardiovascular Institute of the South Venous disease, or venous insufficiency, occurs when the veins in the legs ...
W. L. Gore & Associates' medical business (Gore) today announced trial results evaluating the investigational GORE® VIABAHN® ...
Medical Device Network on MSN
Gore’s venous stent study meets primary endpoint
W. L. Gore & Associates’ medical division has reported that a study of the GORE VIABAHN FORTEGRA Venous Stent met its primary endpoint.
LACONIA — Concord Hospital recently hired two new physicians — Jenaya Goldwag and Augustin James DeLago — and to its ...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine through education and research, today announced results from the Late-Breaking Clinical Trials ...
CalciMedica Inc. ("CalciMedica" or the "Company") (Nasdaq: CALC), a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition ...
NEW YORK, Nov. 13, 2025 /PRNewswire/ -- Koya Medical ("Koya"), an emerging medtech innovator advancing patient-centered ...
Rare vascular and inflammatory conditions such as blood clots, myocarditis, and pericarditis occur more often in children ...
Palvella’s recently expanded rare disease pipeline now comprises QTORIN™-derived product candidates advancing in four serious ...
The target lesion primary patency (TLPP)1 and access circuit primary patency (ACPP)2 of the WRAPSODY® Cell-Impermeable Endoprosthesis (CIE) ...
US FDA grants 510(k) clearance to InterVene’s Recana Thrombectomy Catheter System for venous in-stent restenosis and native vessel obstructions: Redwood City, California Monday, ...
The global population is ageing and this demographic shift has profound effects on haemostasis, notably a progressive tilt ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback